Lasa Supergenics Share Price

₹ 4.44

-₹0.23 (-4.93%)

Last updated 02 Nov, 2026, 15:28 IST

NSE: LASA

Lasa Supergenics Share Price Today

As of 9 Nov 2026, Lasa Supergenics share price is ₹4.44. The stock opened at ₹4.44, compared to its previous close of ₹4.67. During today's trading session, Lasa Supergenics share price moved in the range of ₹4.44 to ₹4.65, with an average price of ₹4.54 for the day. Looking at its last 52-week, the stock has touched a low of ₹4.44 and a high of ₹12.48.

₹4.44

4.93% down today

₹4.65

1D LOW

1D HIGH

Lasa Supergenics Stock Insights

Stock Performance

UnderperformingUnderperforming Nifty by 56.72 % in last 1 yr

Lasa Supergenics Stock Insights

Stock Performance

UnderperformingUnderperforming Nifty by 56.72 % in last 1 yr

Lasa Supergenics stock performance
Open	₹4.44
High	₹4.65
Low	₹4.44
Prev. close	₹4.67

Lasa Supergenics trading activity
Volume	53,166
Average traded price	₹4.44
Last traded time	03:28:08 02 Nov
Last traded quantity	100

₹4.22₹4.66

Circuit Low

Circuit High

₹4.44₹12.48

52-Week Low

52-Week High

Circuit

₹4.22

₹4.66

52-week

₹4.44

₹12.48

Mkt Cap Cr

23.95

P/E

-1.45

P/B

0.48

ROA

-24.96%

ROE

-26.3%

ROCE

-22.21%

Quick Ratio

0.51

EV/EBITDA

-3.47

Mkt Cap Cr

23.95

P/E

-1.45

P/B

0.48

ROA

-24.96%

ROE

-26.3%

ROCE

-22.21%

Quick Ratio

0.51

EV/EBITDA

-3.47

Based on fundamentals, this stock's

Performance

Very Poor

Lasa Supergeneri has not beaten FD return of 7%

Valuation

Overvalued

Lasa Supergeneri appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,59,496.64	40.62	5.0	9.61%	13.79%	18.65%	2.31	23.35
Divis Laboratories	2,73,565.37	87.47	16.34	13.32%	15.32%	19.56%	3.5	62.27
Torrent Pharmaceuticals	1,81,473.50	86.46	9.88	4.7%	11.42%	11.37%	0.75	34.53
Laurus Labs	1,26,162.90	96.11	21.13	11.58%	22.11%	20.91%	0.68	53.3
Zydus Lifesciences	1,19,201.71	27.71	4.29	7.63%	15.1%	14.86%	0.91	16.0
Dr. Reddy's Laboratories	1,14,532.44	41.5	2.95	4.79%	7.21%	8.58%	1.35	19.35
Cipla	1,13,988.97	39.88	3.22	6.6%	8.18%	10.8%	2.5	21.52
Mankind Pharma	1,04,913.45	46.35	5.97	7.82%	12.76%	14.68%	0.74	25.47
Aurobindo Pharma	1,03,395.41	25.93	2.62	6.46%	10.13%	12.76%	1.15	12.49
Lupin	91,001.31	17.43	3.78	13.08%	21.65%	24.54%	1.42	10.19

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lasa Supergenics Company Background

ISIN

INE670X01014

Sector Market Cap

₹ 23.95 Cr

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. It specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located in Chiplun, Maharashtra.

Lasa Supergenics Financial Highlights

Revenue: Lasa Supergenics reported revenue of ₹25.34 crore in FY26 vs ₹147.46 crore in FY25. It showed a decrease of 82.82% on a yearly basis.
Operating Profit: Lasa Supergenics reported an operating loss of ₹34.61 crore in FY26 vs ₹19.38 crore in FY25. It showed a decrease of 78.59% on a year-on-year basis.
Net Profit: Lasa Supergenics reported a net loss of ₹34.09 crore in FY26 vs ₹14.76 crore in FY25. It showed a decrease of 130.96% on a yearly basis.

Lasa Supergenics Quarterly Result Highlights

Lasa Supergenics reported revenue of ₹1.33 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, representing an increase of 1,577.78% on a quarter-on-quarter (QoQ) basis.
Lasa Supergenics reported an operating loss of ₹3.47 crore in Jun 2026, compared with ₹3.98 crore in Mar 2026, representing an increase of 12.81% on a quarter-on-quarter (QoQ) basis.
Lasa Supergenics reported a loss of ₹3.58 crore in Jun 2026, compared with ₹4.16 crore in Mar 2026, reflecting an increase of 13.94% on a QoQ basis.
The earnings per share (EPS) of Lasa Supergenics stood at ₹6.80 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

53.65%

FII

0.00%

Other DII

0.00%

Retail and other

46.35%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Sep 2026	0.00%

Lasa Supergenics Investment Returns

1 day

1 week

1 month

1 year

3 years

5 years

Lasa Supergenics Share Price History

Lasa Supergenics share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹4.44 / ₹4.44	-4.93%
26 Oct 26	₹4.86 / ₹4.67	-4.89%
19 Oct 26	₹5.16 / ₹4.91	-4.84%
12 Oct 26	₹5.06 / ₹5.16	-3.01%
05 Oct 26	₹5.32 / ₹5.32	-5.00%
28 Sep 26	₹5.60 / ₹5.60	-4.92%
21 Sep 26	₹5.89 / ₹5.89	-5.00%
15 Sep 26	₹6.20 / ₹6.20	-4.91%
09 Sep 26	₹6.71 / ₹6.52	-2.54%
08 Sep 26	₹6.70 / ₹6.69	+0.15%

Lasa Supergenics Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹25.14	₹142.45	₹104.34	₹129.57
Other Income	₹0.20	₹5.01	₹0.10	₹1.80
Total Revenue	₹25.34	₹147.46	₹104.43	₹131.37
Total Expenses	₹38.91	₹151.17	₹114.77	₹153.74
Profit Before Tax	-₹34.61	-₹19.38	-₹19.11	-₹42.27
Tax	-₹0.52	-₹4.63	₹2.62	-₹3.64
Profit After Tax	-₹34.09	-₹14.76	-₹21.73	-₹38.62
EPS - Basic	-₹6.80	-₹2.95	-₹4.34	-₹7.71
EPS - Diluted	-₹6.80	-₹2.95	-₹4.34	-₹7.71

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	-₹34.61	-₹19.38	-₹19.11	-₹22.37
Income before WC changes	-₹8.67	₹9.10	-₹10.69	-₹26.44
Change in Assets	₹11.40	-₹3.81	₹6.82	₹12.24
Change in Liabilities	-₹10.42	-₹8.17	₹6.01	-₹3.06
Change in WC	₹0.97	-₹11.98	₹12.83	₹9.18
Cash flow from Operations	-₹7.69	-₹2.88	₹2.14	-₹17.30
Cash flow from Investing	₹0.34	₹8.21	-₹0.40	₹11.19
Cash flow from Financing	₹7.37	-₹5.66	-₹1.93	-₹4.16
Total Cash Flow	₹0.01	-₹0.33	-₹0.19	-₹10.27
Cash (Start of the year)	₹0.28	₹0.61	₹0.80	₹11.07
Cash (End of the year)	₹0.29	₹0.28	₹0.61	₹0.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹55.83	₹69.02	₹112.98	₹124.63
Current Assets	₹10.44	₹32.51	₹37.89	₹39.22
Total Assets	₹66.27	₹101.53	₹150.87	₹163.85
Current Liabilities	₹16.77	₹17.15	₹48.87	₹42.73
Net Current Asset	-₹6.34	₹15.36	-₹10.98	-₹3.51
Non-Current Liabilities	-₹0.12	₹0.66	₹5.32	₹2.84
Equity Capital	₹49.62	₹83.71	₹96.68	₹118.29
Total Equity & Liabilities	₹66.27	₹101.53	₹150.87	₹163.85